Cargando…
AB014. Effective somatostatin analogs in a case of advanced thymoma with no uptake in the octreotide scan
BACKGROUND: Management of advanced malignant thymoma is very challenging due to the lack of evidence from randomized trials. Despite advanced and non-curable status, most patients achieve long survival and they usually receive several treatment lines along their disease. There is no standard second...
Autores principales: | Mielgo-Rubio, Xabier, Hernando Polo, Susana, Jiménez Aguilar, Elisabeth, Olier Garate, Clara, Hurtado Nuño, Alicia, Moreno Muñoz, Diana, Sánchez Becerra, Maria Virginia, González López, Andrea María, Esteban García, Mónica, Robles Bermejo, Teresa, Barón, Manuel, Hernando Trancho, Florentino, Ramón Jarabo, Jose, Cámara Vicario, Juan Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792819/ http://dx.doi.org/10.21037/med-22-ab014 |
Ejemplares similares
-
Thoracic surgery in Spain
por: Varela, Gonzalo, et al.
Publicado: (2022) -
Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020) -
Effects of somatostatin/octreotide treatment in neonates with congenital chylothorax
por: Yin, Rong, et al.
Publicado: (2017) -
When the Need is Greater Than Feasible
por: Fraile Olivero, Carlos Alfredo, et al.
Publicado: (2020) -
Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
por: Nilsson, O., et al.
Publicado: (1998)